Two of Astellas Pharma most sold products increase the risk of PRES in already vulnerable patients
Register to read the full analysis —or— Upgrade to access more features
#illnesses
#side-effects
#negative health
#cancer
#PRES
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.